Rybelsus (semaglutide) is a prescription drug that’s used to manage blood sugar levels in adults with type 2 diabetes. Rybelsus comes as a tablet that you’ll swallow with a little water each day.

Rybelsus comes as tablets that you’ll take by mouth. It’s available in two formulations, which come in the following strengths: Formulation R1 comes in 3 milligrams (mg), 7 mg, and 14 mg.

According to the U.S. Food and Drug Administration (FDA), the maximum 14 milligram (mg) daily dose of Rybelsus is equivalent to the 0.5 mg weekly starter dose of Ozempic — one can be switched ...

According to the drug’s website, results from a six-month study with 703 adults with type 2 diabetes compared 7 mg and 14 mg Rybelsus with a sugar pill when both were taken with adjustments to ...

Rybelsus is following in Ozempic’s footsteps as a blockbuster seller. Novo Nordisk reported more than 7.2 billion Danish krone (more than $1 billion) in sales for the pill through the first nine ...

The Food and Drug Administration approved Novo Nordisk’s Rybelsus for use as a first-line treatment ... it can now be prescribed as initial therapy for type 2 diabetes in 7 or 14 mg. Before the latest ...